A Clinical Decision Support System and Patient Portal for Preventing Medication-related Falls in Older Patients

NCT05449470 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2023-02-02

No results posted yet for this study

Summary

Falls in older adults represents a growing public health challenge. The use of certain medication is recognized as an important modifiable risk factor for falls. Research indicates fall-risk increasing drug (FRID) deprescribing is effective in reducing falls but difficult to initiate and to sustain over longer periods of follow-up. A clinical decision support system (CDSS) and patient portal for communicating medication-related fall risk to fall clinic patients may improve joint medication management between patients and physicians and consequently reduce the incidence of injurious falls.

Conditions

  • Fall
  • Fall Injury
  • Fall Patients
  • Accidental Fall
  • Deprescriptions
  • Polypharmacy
  • Aged
  • Aged, 80 and Over

Interventions

DEVICE

CDSS

A clinical decision support system (CDSS) that provides deprescribing advice and a personalized risk prediction

DEVICE

Patient Portal

A Patient Portal that helps patients prepare for their fall clinic visit by giving them information about falls, falls prevention, and medication-related falls. After the fall clinic visit, the Patient Portal also shows the personalized fall-risk and treatment advice.

Sponsors & Collaborators

  • VU University of Amsterdam

    collaborator OTHER
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Nathalie van der Velde, MD, PhD · Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  • Natasja M van Schoor, PhD · Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health, Amsterdam, the Netherlands

  • Annemiek J Linn, PhD · Amsterdam School of Communication Research, University of Amsterdam, Amsterdam, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-07
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05449470 on ClinicalTrials.gov